GWN Securities Inc. Sells 2,556 Shares of Cardinal Health, Inc. $CAH

GWN Securities Inc. lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,870 shares of the company’s stock after selling 2,556 shares during the quarter. Cardinal Health makes up approximately 1.1% of GWN Securities Inc.’s holdings, making the stock its 15th biggest holding. GWN Securities Inc.’s holdings in Cardinal Health were worth $4,729,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. raised its stake in shares of Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after acquiring an additional 150 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its position in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the last quarter. Vermillion & White Wealth Management Group LLC increased its holdings in Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 71 shares in the last quarter. NewSquare Capital LLC raised its position in Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after purchasing an additional 107 shares during the last quarter. Finally, Quent Capital LLC acquired a new position in Cardinal Health in the third quarter worth $35,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (>$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook
• Positive Sentiment: Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. Benzinga: Cardinal Health Lifts 2026 Profit Outlook
• Positive Sentiment: Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. Barron’s: Cardinal Health Stock Jumps on Guidance Raise
• Neutral Sentiment: The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. Seeking Alpha: J.P. Morgan Presentation Transcript
• Neutral Sentiment: Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. Yahoo Finance: Analyst Upgrades & Specialty Focus
• Negative Sentiment: Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)
• Negative Sentiment: Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. Yahoo Finance: Has Cardinal Health Run Too Far?

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Jefferies Financial Group set a $220.00 target price on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Leerink Partners set a $240.00 price objective on shares of Cardinal Health in a research report on Tuesday. Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a research note on Friday, October 31st. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Finally, Argus boosted their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Fourteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $214.07.

Cardinal Health Price Performance

CAH opened at $208.08 on Wednesday. The firm has a 50 day simple moving average of $204.54 and a 200 day simple moving average of $173.77. Cardinal Health, Inc. has a fifty-two week low of $119.92 and a fifty-two week high of $214.93. The company has a market cap of $49.44 billion, a price-to-earnings ratio of 31.38, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.